These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 10211419
1. Neopterin serum levels in pancreatic adenocarcinoma. Manes G, Spada OA, Rabitti PG, Feola B, Misso S, Minerva A, Uomo G. Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419 [Abstract] [Full Text] [Related]
2. Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis. Talar-Wojnarowska R, Gasiorowska A, Olakowski M, Lekstan A, Lampe P, Malecka-Panas E. Pancreatology; 2010 Feb; 10(6):689-94. PubMed ID: 21242708 [Abstract] [Full Text] [Related]
3. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Chang MC, Liang PC, Jan S, Yang CY, Tien YW, Wei SC, Wong JM, Chang YT. Pancreatology; 2014 Feb; 14(5):366-72. PubMed ID: 25278306 [Abstract] [Full Text] [Related]
4. Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer? Kayhan B, Kayhan B, Akdoğan M. Int J Biol Markers; 2004 Feb; 19(3):196-202. PubMed ID: 15503821 [Abstract] [Full Text] [Related]
5. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis. Pezzilli R, Billi P, Beltrandi E, Mancini R, Casadei-Maldini M, Casadei R, Greco VM, Campione O, Miglioli M. Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340 [Abstract] [Full Text] [Related]
6. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Grüngreiff K, Reinhold D, Ansorge S. Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433 [Abstract] [Full Text] [Related]
7. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer. Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V. Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196 [Abstract] [Full Text] [Related]
8. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Doganay S, Evereklioglu C, Er H, Türköz Y, Sevinç A, Mehmet N, Savli H. Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817 [Abstract] [Full Text] [Related]
9. Prognostic significance of soluble interleukin-2 receptor-alpha in adenocarcinoma of the pancreas. Gansauge F, Steinbach G, Gansauge S, König HH, Müller J, Grünert A, Beger HG. Cancer Lett; 1998 Dec 25; 134(2):193-9. PubMed ID: 10025881 [Abstract] [Full Text] [Related]
10. Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2. Lissoni P, Tisi E, Brivio F, Barni S, Rovelli F, Perego M, Tancini G. Eur J Cancer; 1991 Dec 25; 27(8):1014-6. PubMed ID: 1832885 [Abstract] [Full Text] [Related]
11. Neopterin in acute pancreatitis. Uomo G, Spada OA, Manes G, Feola B, Misso S, Cavallera A, Rabitti PG. Scand J Gastroenterol; 1996 Oct 25; 31(10):1032-6. PubMed ID: 8898426 [Abstract] [Full Text] [Related]
12. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Maire F, Micard S, Hammel P, Voitot H, Lévy P, Cugnenc PH, Ruszniewski P, Puig PL. Br J Cancer; 2002 Aug 27; 87(5):551-4. PubMed ID: 12189555 [Abstract] [Full Text] [Related]
13. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients. Crispino S, Lissoni P, Ardizzoia A, Rovelli F, Perego MS, Grassi MG, Barni S, Pittalis S, Tancini G. J Biol Regul Homeost Agents; 1993 Aug 27; 7(3):92-4. PubMed ID: 8135145 [Abstract] [Full Text] [Related]
14. Levels of serum neopterin are increased in pancreatic cancer patients and correlate with the prognosis. Birk D, Gansauge F, Gansauge S, Schwarz A, Beger HG. Eur J Med Res; 1999 Apr 27; 4(4):156-60. PubMed ID: 10205291 [Abstract] [Full Text] [Related]
15. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Evereklioglu C, Er H, Türköz Y, Cekmen M. Mediators Inflamm; 2002 Apr 27; 11(2):87-93. PubMed ID: 12061429 [Abstract] [Full Text] [Related]
16. Low serum levels of CD44, CD44v6, and neopterin indicate immune dysfunction in chronic pancreatitis. Schlosser W, Gansauge F, Schlosser S, Gansauge S, Beger HG. Pancreas; 2001 Nov 27; 23(4):335-40. PubMed ID: 11668200 [Abstract] [Full Text] [Related]
17. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass. Hogendorf P, Durczyński A, Skulimowski A, Kumor A, Poznańska G, Strzelczyk J. Cancer Biomark; 2018 Feb 14; 21(3):505-511. PubMed ID: 29171983 [Abstract] [Full Text] [Related]
18. Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology. Ferri MJ, Saez M, Figueras J, Fort E, Sabat M, López-Ben S, de Llorens R, Aleixandre RN, Peracaula R. PLoS One; 2016 Feb 14; 11(1):e0147214. PubMed ID: 26808421 [Abstract] [Full Text] [Related]
19. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma? Rabitti PG, Pacelli L, Uomo G, Laccetti M, Spada OA, Esposito G, Visconti M. Minerva Gastroenterol Dietol; 1994 Sep 14; 40(3):101-3. PubMed ID: 7948318 [Abstract] [Full Text] [Related]